{"id":60150,"date":"2022-12-09T02:36:03","date_gmt":"2022-12-09T02:36:03","guid":{"rendered":"https:\/\/haberulus.net\/?p=60150"},"modified":"2022-12-09T02:36:03","modified_gmt":"2022-12-09T02:36:03","slug":"ilacta-yoklugun-sebebi-maliyet-ve-tedarik","status":"publish","type":"post","link":"https:\/\/haberulus.net\/?p=60150","title":{"rendered":"\u0130la\u00e7ta yoklu\u011fun sebebi maliyet ve tedarik"},"content":{"rendered":"<p><strong>Pandemi<\/strong> sonras\u0131nda h\u0131zlanan ila\u00e7 krizinde eczac\u0131lara g\u00f6re d\u00f6rt ila\u00e7tan biri yok kategorisine girerken, \u00fcretici \u015firketler ise \u00e7\u00f6z\u00fcm i\u00e7in tedarik sorunu ve y\u00fcksek maliyetlere i\u015faret etti.\u00a0 Piyasada h\u00e2l\u00e2 ambalaj ve \u015fi\u015fe bulamayan \u015firketler oldu\u011funu, hammadde fiyatlar\u0131n\u0131n d\u00f6viz baz\u0131nda y\u00fckselmesi ile \u00fcretimin s\u0131k\u0131nt\u0131ya girebildi\u011fini kaydeden Abdi \u0130brahim Genel M\u00fcd\u00fcr\u00fc S\u00fcha Ta\u015fpolato\u011flu, \u201cSadece T\u00fcrkiye&#8217;de de\u011fil t\u00fcm d\u00fcnyada hammadde ya da \u00e7e\u015fitli yard\u0131mc\u0131 maddelerin ve ambalaj malzemelerinin eri\u015fiminde s\u0131k\u0131nt\u0131lar var. Bu d\u00f6nemde ila\u00e7 yokluklar\u0131nda ana sebeplerden biri bu. Bir di\u011fer neden e\u011fer maliyetler yeterli de\u011filse firmalar \u00fcr\u00fcnleri piyasaya verme konusunda geri durabiliyorlar\u201d dedi. Ta\u015fpolato\u011flu, 2023&#8217;\u00fcn ilk yar\u0131s\u0131n\u0131n ila\u00e7 alan\u0131nda benzer bir tabloya i\u015faret etti\u011fini, ila\u00e7 fiyat kararnamesi kapsam\u0131nda da y\u00fczde 30&#8217;luk bir fiyat art\u0131\u015f\u0131 olabilece\u011fini dile getirdi.<\/p>\n<p><strong>TALEP Y\u00dcKSEK <\/strong><\/p>\n<p>GSK T\u00fcrkiye Genel M\u00fcd\u00fcr\u00fc Selim Giray ise \u201cHem talep y\u00fckseliyor hem de arzda tedarikte s\u0131k\u0131nt\u0131lar var. Zor bir d\u00f6neme yakaland\u0131k. T\u00fcrkiye&#8217;ye mahsus bir durum de\u011fil. D\u00fcnya genelinde baz\u0131 \u00fcr\u00fcnlere talep \u00e7ok artt\u0131. Pani\u011fe gidecek hi\u00e7bir durum yok. Hepsi\u00a0 y\u00f6netilebilir yeter ki m\u00fc\u015fterek bir yol haritas\u0131nda ilerlensin\u201d de\u011ferlendirmesini yapt\u0131.<\/p>\n<p><b>Avustralya&#8217;daki \u00fcretimi T\u00fcrkiye&#8217;ye kayd\u0131rd\u0131<\/b><\/p>\n<p>Sekt\u00f6r\u00fcn iki b\u00fcy\u00fck temsilcisi Abdi \u0130brahim ve GSK T\u00fcrkiye i\u015fbirli\u011fine giderek yat\u0131r\u0131m tutar\u0131 340 milyon T\u00fcrk Liras\u0131&#8217;n\u0131 bulan ve solunum yolu hastal\u0131klar\u0131n\u0131n tedavisinde kullan\u0131lan en ileri \u2018neb\u00fcl&#8217; teknolojisini T\u00fcrkiye&#8217;ye getirdi. GSK&#8217;n\u0131n Avustralya fabrikas\u0131ndaki \u00fcretiminin Abdi \u0130brahim tesislerine kayd\u0131r\u0131lmas\u0131 ile birlikte 5 y\u0131l i\u00e7inde cari a\u00e7\u0131\u011f\u0131n yakla\u015f\u0131k 2 milyar TL kapanmas\u0131na katk\u0131 sa\u011flayaca\u011f\u0131 belirtildi. Proje kapsam\u0131nda 600 milyon adet neb\u00fcl \u00fcretilmesi hedefleniyor.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Farkl\u0131 hastal\u0131klar\u0131n tedavisinde kullan\u0131lan pek \u00e7ok ilaca eczane raflar\u0131nda ula\u015fmak zorla\u015f\u0131rken, \u00fcretici \u015firketler s\u0131k\u0131nt\u0131n\u0131n maliyet ve tedarik sorunu nedeniyle ya\u015fand\u0131\u011f\u0131n\u0131 aktard\u0131.<\/p>\n","protected":false},"author":1,"featured_media":60151,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[25],"tags":[1564,15],"class_list":["post-60150","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ekonomi","tag-ilac","tag-turkiye"],"_links":{"self":[{"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/posts\/60150","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/haberulus.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=60150"}],"version-history":[{"count":1,"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/posts\/60150\/revisions"}],"predecessor-version":[{"id":60152,"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/posts\/60150\/revisions\/60152"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/media\/60151"}],"wp:attachment":[{"href":"https:\/\/haberulus.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=60150"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haberulus.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=60150"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/haberulus.net\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=60150"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}